Immunogenicity and safety of concomitant and sequential administration of yellow fever yf-17d vaccine and tetravalent dengue vaccine candidate tak-003: a phase 3 randomized, controlled study

HIGHLIGHTS

• who: Vianney Tricou and colleagues from the Editor: EClapham, National University have published the Article: Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study, in the Journal: (JOURNAL)
• what: The aim was to demonstrate non-inferiority (upper bound of 95% confidence Results adults were randomized. seroprotection rates one month post-YF-17D (Month / __NEWPAGE__PLOS NEGLECTED TROPICAL DISEASES scope system-compatibility and meeting sponsor policies) and will then be reviewed by an independent review panel. The aim of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.